Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.96
-4.79 (-19.35%)
May 7, 2026, 12:39 PM EDT - Market open

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6051,1557595926251,088
Market Cap Growth
-4.62%52.13%28.33%-5.37%-42.55%-34.70%
Enterprise Value
524.86890.46490.35362.62377.98765.24
Last Close Price
19.9638.9026.6521.5823.5442.87
PE Ratio
--46.8742.98-10.08-9.12-34.57
PS Ratio
2.213.352.292.694.5611.56
PB Ratio
1.632.451.671.511.572.64
P/TBV Ratio
1.272.401.711.481.542.62
P/FCF Ratio
165.9640.7720.77-30.73-13.22-48.43
P/OCF Ratio
15.5417.9511.70-105.14-15.01-57.31
EV/Sales Ratio
1.542.591.481.652.768.13
EV/EBITDA Ratio
--436.7219.88-6.52-6.07-20.87
EV/EBIT Ratio
--20.8056.56-5.33-5.19-19.09
EV/FCF Ratio
116.1731.4413.42-18.84-7.99-34.06
Debt / Equity Ratio
0.070.070.050.040.030.02
Debt / EBITDA Ratio
-2.00-18.101.07-0.28-0.21-0.22
Debt / FCF Ratio
8.131.300.72-0.80-0.28-0.36
Net Debt / Equity Ratio
-0.49-0.56-0.58-0.58-0.61-0.78
Net Debt / EBITDA Ratio
12.26128.79-10.824.093.948.77
Net Debt / FCF Ratio
-49.79-9.27-7.3011.835.1914.31
Asset Turnover
0.600.620.670.490.300.21
Inventory Turnover
7.267.737.497.5510.677.47
Quick Ratio
6.234.996.975.907.8113.94
Current Ratio
6.755.267.296.208.0914.21
Return on Equity (ROE)
-4.80%-5.24%4.31%-14.54%-16.56%-11.78%
Return on Assets (ROA)
-7.40%-6.32%1.49%-15.12%-15.60%-10.82%
Return on Invested Capital (ROIC)
-18.35%-17.38%4.14%-42.82%-53.86%-76.57%
Return on Capital Employed (ROCE)
-6.60%-8.63%1.95%-16.64%-17.16%-9.36%
Earnings Yield
-1.71%-2.13%2.33%-9.92%-10.96%-2.89%
FCF Yield
0.60%2.45%4.81%-3.25%-7.57%-2.06%
Buyback Yield / Dilution
-4.45%0.92%-9.15%-2.87%-3.65%-32.80%
Total Shareholder Return
-4.45%0.92%-9.15%-2.87%-3.65%-32.80%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q